REGEnLIFE SAS
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Efficacy of RGn600 in Patients With Mild-to-moderate Alzheimer's Disease (NCT05926011) | REGEnLIFE SAS | 2023-07-24 |
| Pilot Clinical Investigation Evaluating the Safety and Performance of RGn550 in Treating Sportspeople Suffering From Acute Concussion Syndrome (NCT05647304) | REGEnLIFE SAS | 2022-10-11 |
Track REGEnLIFE SAS automatically
Every clearance here is in the API, with alerts when new ones post.